Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

52.38 +0.85 (+1.64%)
Streaming Delayed Price Updated: 2:33 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,133,856
Open 51.30
Bid (Size) 52.36 (8)
Ask (Size) 52.48 (8)
Prev. Close 51.53
Today's Range 50.53 - 54.28
52wk Range 11.21 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
Viking Therapeutics' Phase 2b results show VK2809's efficacy in treating NASH, with significant liver fat reductions, NASH resolution, and fibrosis improvement. 
Via Benzinga
Money In Motion: Top Picks To Power Your Portfolio Today
Top stocks set to dominate the market today. 
Via Talk Markets

Performance

YTD
+186.52%
+186.52%
1 Month
-18.60%
-18.60%
3 Month
-19.12%
-19.12%
6 Month
-16.88%
-16.88%
1 Year
+361.46%
+361.46%

More News

Read More
3 Things You Need to Know if You Buy Viking Therapeutics Today
Via The Motley Fool
Is It Too Late to Buy Viking Therapeutics Stock?
Via The Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
Via The Motley Fool
Topics Government
Exposures Political
Market Whales and Their Recent Bets on VKTX Options
Via Benzinga
Unpacking the Latest Options Trading Trends in Viking Therapeutics
Via Benzinga
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Via Benzinga
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Via The Motley Fool
Is Viking Therapeutics a Buy on the Dip?
Via The Motley Fool
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
Via The Motley Fool
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
Via The Motley Fool
Is Viking Therepautics a Buy Now?
Via The Motley Fool
Why Viking Therapeutics Stock Plummeted After Soaring Today
Via The Motley Fool
Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety
Via Benzinga
Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data
Via Investor's Business Daily
MarketBeat Week in Review – 10/28 - 11/1
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
Via Investor's Business Daily
Viking Therapeutics Stock: A Pre-Election Bet Worth Considering
Via MarketBeat
This High-Flying Stock Just Became a Better Buy
Via The Motley Fool
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
Via The Motley Fool
S&P 500, Nasdaq Rise Sharply Ending 3-Day Losing Streak; Viking Therapeutics Surge, While Capri’s Shares Slump
Via Talk Markets
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.